Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).
D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D002986:Clinical Trials as Topic; D003201:Computers; D003863:Depression / Q000188:drug therapy; D003984:Dibenzazepines / Q000494:pharmacology* / Q000627:therapeutic use; D003989:Dibenzoxazepines / Q000627:therapeutic use; D004361:Drug Tolerance; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010555:Personality Inventory; D011569:Psychiatric Status Rating Scales; D011719:Pyrazines / Q000494:pharmacology* / Q000627:therapeutic use; D014363:Tryptamines / Q000037:antagonists & inhibitors
D000928:Antidepressive Agents; D003984:Dibenzazepines; D003989:Dibenzoxazepines; D011719:Pyrazines; D014363:Tryptamines; D000639:Amitriptyline